Survival in patients treated for anaplastic meningioma

Journal of Neurosurgery

Volumn 123, Issue 1, 2015, Pages 23-30

  Moliterno, Jennifer ^a   Cope, William P ^b   Vartanian, Emma D ^b   Reiner, Anne S ^c   Kellen, Roselyn ^b   Ogilvie, Shahiba Q ^b   Huse, Jason T ^b   Gutin, Philip H ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Department of Epidemiology and Biostatistics ^*  (United States)

Author keywords

Anaplastic meningioma; Oncology; Outcome; Survival

Indexed keywords

BEVACIZUMAB;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ANAPLASTIC MENINGIOMA; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRANIOTOMY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; LUNG METASTASIS; MALE; MENINGIOMA; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; TUMOR GROWTH; CLASSIFICATION; DISEASE COURSE; KAPLAN MEIER METHOD; MENINGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; PROCEDURES; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; CRANIOTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84940392166     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2014.10.JNS14502     Document Type: Article

References (39)

1. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M: Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210-218, 2004
2. Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, et al: Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661-669, 2001
3. Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, et al: Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077-1080, 2013
4. Dropcho EJ, Soong SJ: The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a casecontrol study. Neurology 47:684-690, 1996
5. Drummond KJ, Bittar RG, Fearnside MR: Metastatic atypical meningioma: case report and review of the literature. J Clin Neurosci 7:69-72, 2000
6. Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, et al: Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 37:177-188, 1998
7. Enam SA, Abdulrauf S, Mehta B, Malik GM, Mahmood A: Metastasis in meningioma. Acta Neurochir (Wien) 138: 1172-1178, 1996
8. Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, et al: Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 182:641-646, 2006
9. Figueroa BE, Quint DJ, McKeever PE, Chandler WF: Extracranial metastatic meningioma. Br J Radiol 72:513-516, 1999
10. Hanft S, Canoll P, Bruce JN: A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol 99:433-443, 2010
11. Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al: Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151-160, 2000
12. Jääskeläinen J, Haltia M, Servo A: Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242, 1986
13. Kleihues P, Sobin LH: World Health Organization classification of tumors. Cancer 88:2887, 2000
14. Krayenbïhl N, Pravdenkova S, Al-Mefty O: De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome. Neurosurgery 61:495-504, 2007
15. Lamszus K: Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275-286, 2004
16. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al: The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol 114:97-109, 2007 (Erratum in Acta Neuropathol 114:547, 2007)
17. Lïdemann WO, Obler R, Tatagiba M, Samii M: Seeding of malignant meningioma along a surgical trajectory on the scalp. Case report and review of the literature. J Neurosurg 97:683-686, 2002
18. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM: Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33:955-963, 1993
19. Miller DC, Ojemann RG, Proppe KH, McGinnis BD, Grillo HC: Benign metastasizing meningioma. Case report. J Neurosurg 62:763-766, 1985
20. Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ: Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34:817-822, 1996
21. Modha A, Gutin PH: Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538-550, 2005
22. Nayak L, Iwamoto FM, Rudnick JD, Norden AD, Lee EQ, Drappatz J, et al: Atypical and anaplastic meningiomas treated with bevacizumab. J Neurooncol 109:187-193, 2012
23. Ohgaki H, Kleihues P: The definition of primary and secondary glioblastoma. Clin Cancer Res 19:764-772, 2013
24. Ozaki S, Nishizaki T, Ito H, Sasaki K: Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma. J Neurooncol 41:167-174, 1999
25. Palma L, Celli P, Franco C, Cervoni L, Cantore G: Longterm prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86:793-800, 1997
26. Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M, et al: Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 71:1388-1393, 2008
27. Perry A, Banerjee R, Lohse CM, Kleinschmidt-DeMasters BK, Scheithauer BW: A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 12:183-190, 2002
28. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC: Malignancy in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046-2056, 1999
29. Riemenschneider MJ, Perry A, Reifenberger G: Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045-1054, 2006
30. Rosenberg LA, Prayson RA, Lee J, Reddy C, Chao ST, Barnett GH, et al: Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys 74:427-432, 2009
31. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39, 1957
32. Sughrue ME, Sanai N, Shangari G, Parsa AT, Berger MS, McDermott MW: Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg 113:202-209, 2010
33. Tominaga T, Koshu K, Narita N, Yoshimoto T: Metastatic meningioma to the second cervical vertebral body: a case report. Neurosurgery 34:538-540, 1994
34. Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, et al: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94:14719-14724, 1997
35. Wen PY, Quant E, Drappatz J, Beroukhim R, Norden AD: Medical therapies for meningiomas. J Neurooncol 99:365-378, 2010
36. Whittle IR, Smith C, Navoo P, Collie D: Meningiomas. Lancet 363:1535-1543, 2004
37. Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71:487-493, 1989
38. Yamashita J, Handa H, Iwaki K, Abe M: Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol 14:33-40, 1980
39. Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW: Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79:574-580, 2008